Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Exploratory INDs Will Better Serve Large Companies, PDL Exec Says

Executive Summary

Exploratory investigational new drug applications will provide a greater benefit to large pharma and biotech companies, Protein Design Labs CEO Mark McDade said at the Biotechnology Industry Organization Windhover conference in Washington, D.C. April 26

You may also be interested in...



FDA Stressing Statistical Outcomes Over Standardization In Imaging Trials

FDA is emphasizing statistical outcomes over protocol standardization when assessing imaging studies, according to Division of Medical Imaging Drug Products Director George Mills

FDA Stressing Statistical Outcomes Over Standardization In Imaging Trials

FDA is emphasizing statistical outcomes over protocol standardization when assessing imaging studies, according to Division of Medical Imaging Drug Products Director George Mills

Exploratory IND Concept Needs Expansion, Merck Exec Says

FDA should expand its "Exploratory IND" guidance to make it easier for manufacturers to do pilot studies involving radioactive tracers, Merck Division of Imaging Senior Director David Mozley told a May 5 meeting on "Critical Path" opportunities cosponsored by FDA, the Biotechnology Industry Organization and the Drug Information Association in Bethesda, Md

Topics

UsernamePublicRestriction

Register

PS045740

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel